Specialty Services Oncology

 

 Tumor Biology and Molecular Pharmacology

  • Angiogenesis
    • Aortic ring explant assay
    • Cell migration assay
    • Tube formation assay
    • VEGFR2 kinase assay
  • Metastasis Assays
    • Malignant cell invasion assay
    • Proliferation
      • MMT, SRB, and XTT assays
    • Biology techniques
      • RT-PCR, Western, ELISA, FACS
    • Ex vivo pharmacology
      • Tissue necropsy and process
      • RT-PCR, Western, ELISA, kinase activity
    • Histology
      • Histopathology
      • Immunohistochemistry
  •  
 

 Subcutaneous Xenograft Models

 
 

 Orthotopic Xenograft Models

Special focus on GI tract cancer:
Additional expertise in breast, kidney, spleen, prostate and brain orthotopic implantation.
 

Special Tumor Models

aaadc



aaadc
  • Metastasis models
    • Experimental metastasis models
    • Spontaneous metastasis models
  • Nude rat models
    • (Combinational PK-PD study and local drug delivery)
    • Orthotopic xenograft model
    • Subcutaneous xenograft model
  • Angiogenesis models
    • Matrigel plug
    • Skinfold chamber test
  • Cancer imaging system
 

Human Primary Tumor Models

 

Adjacency Services



aaadc





aaadc
PK/ADME Studies
  • PK/TK sample analysis (LC-MS/MS)
  • PK property characterization (F, T1/2, Cmax, Tmax, CL, Vss, AUC)
  • Dose proportionality • Assessment of hepatic first pass effect and biliary excretion
  • PK/PD relationship • Metabolic stability (microsomes, S9 and hepatocytes)
  • CYP inhibition (IC50, Ki) for DDI • CYP reaction phenotyping
  • Plasma protein binding assay
  • Plasma stability evaluation
Preliminary Toxicity Assessment
  • Sub-acute 7-day and 14-day tox studies
  • LD50 and MTD study
  • Dermal toxicity (rabbits)
  • Blood chemistry and histology
  • Liver toxicity